The Dangers of False-Positive and False-Negative Test Results: False-Positive Results as a Function of Pretest Probability

Clinics in Laboratory Medicine

Volumn 28, Issue 2, 2008, Pages 305-319

  Jackson, Brian R ^a,b  

^a ARUP LABORATORIES   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; CLINICAL PRACTICE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; LABORATORY TEST; PRIORITY JOURNAL; PROBABILITY; REVIEW;

BAYES THEOREM; DIAGNOSTIC ERRORS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; LABORATORIES;

EID: 43049126861     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2007.12.009     Document Type: Review

References (51)

1. Lundberg G.D. The need for an outcomes research agenda for clinical laboratory testing. JAMA 280 6 (1998) 565-566
2. Gluud C., and Gluud L.L. Evidence based diagnostics. BMJ 330 (2005) 724-726
3. Van Walraven C., and Naylor C.D. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA 280 6 (1998) 550-558
4. Merenstein D., Daumit G.L., and Powe N.R. Use and costs of nonrecommended tests during routine preventive health exams. Am J Prev Med 30 6 (2006) 521-527
5. Borrill Z., Houghton C., Sestini P., et al. Retrospective analysis of evidence base for tests used in diagnosis and monitoring of disease in respiratory medicine. BMJ 327 (2003) 1136-1138
6. Graber M.L., Franklin N., and Gordon R. Diagnostic error in internal medicine. Arch Intern Med 165 (2005) 1493-1499
7. Singh H., Thomas E.J., Khan M.M., et al. Identifying diagnostic errors in primary care using an electronic screening algorithm. Arch Intern Med 167 (2007) 302-308
8. Cameron D., Gaito A., Harris N., et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther 2 Suppl 1 (2004) S1-S13
9. Bacon R.M., Biggerstaff B.J., Schriefer M.E., et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant V1sE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 187 (2003) 1197-1199
10. Tugwell P., Dennis D.T., Weinstein A., et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med 127 12 (1997) 1109-1123
11. Gill C.J., Sabin I., and Schmid C.H. Why clinicians are natural Bayesians. BMJ 330 (2005) 1080-1083
12. Bayes T. Studies in the history of probability and statistics: IX. Thomas Bayes' essay towards solving a problem in the doctrine of chances. Biometrika 45 (1958) 296-315
13. Bayes' theorem. Available at: http://en.wikipedia.org/wiki/Bayes'_theorem. Accessed April 13, 2007.
14. Centre for Evidence-Based Medicine. Likelihood ratios. Oxford (England). Available at: http://www.cebm.net/likelihood_ratios.asp. Accessed April 23, 2007.
15. Noguchi Y., Matsui K., Imura H., et al. Quantitative evaluation of the diagnostic thinking process in medical students. J Gen Intern Med 17 (2002) 848-853
16. Redelmeier D.A. The cognitive psychology of missed diagnoses. Ann Intern Med 142 (2005) 115-120
17. McManus R.J., Mant J., Meulendijks C.F.M., et al. Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study. BMJ 324 (2002) 459-464
18. Cahon A., Gilon D., Manor O., et al. Probabilistic reasoning and clinical decision-making: do doctors overestimate diagnostic probabilities?. QJM 96 (2003) 763-769
19. Christensen-Szalanski J.J., and Bushyhead J.B. Physicians' misunderstanding of normal findings. Med Decis Making 3 (1983) 169-175
20. Tversky A., and Kahneman D. Judgment under uncertainty: heuristics and biases. Science 185 4157 (1974) 1124-1131
21. Calfee C.S., Shah S.J., Wolters P.J., et al. Anchors away. N Engl J Med 356 (2007) 504-509 [Anchoring effect]
22. Tversky A., and Kahneman D. Belief in the law of small numbers. Psychol Bull 76 (1971) 105-110
23. Rotmensch S., and Cole L.A. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 355 (2000) 712-715
24. Smith H.O., Wiggins C., Verschraegen C.F., et al. Changing trends in gestational trophoblastic disease. J Reprod Med 51 10 (2006) 777-784
25. Lerman C., Trock B., Rimer B.K., et al. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 114 (1991) 657-661
26. Lafata J.E., Simpkins J., Lamerato L., et al. The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev 13 12 (2004) 2126-2132
27. Holloway R.G., and Reasby T.E. To test or not to test? That is the question. Neurology 53 (1999) 1905-1907
28. Lijmer J.G., Mol B.W., Heisterkamp S., et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 282 11 (1999) 1061-1066
29. Fletcher R.H. Carcinoembryonic antigen. Ann Intern Med 104 (1986) 66-73
30. Nierenberg A.A., and Feinstein A.R. How to evaluate a diagnostic marker test: lessons from the rise and fall of dexamethaxone suppression test. JAMA 259 (1988) 1699-1702
31. Lensing A.W., and Hirsh J. 125I-fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients. Thromb Haemost 69 (1993) 2-7
32. Wang T.J., Gona P., Larson M.G., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355 25 (2006) 2631-2639
33. Folsom A.R., Chambless L.E., Ballantyne C.M., et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers. Arch Intern Med 166 (2006) 1368-1373
34. Zholudev A., Zurakowski D., Young W., et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol 99 11 (2004) 2235-2241
35. Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem 52 2 (2006) 171-181
36. Eisenberg J.M., Schwartz J.S., McCaslin F.C., et al. Substituting diagnostic services: new tests only partly replace older ones. JAMA 262 9 (1989) 1196-1200
37. Morrow D.A., Cannon C.P., Jesse R.L., et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 53 4 (2007) 552-574
38. Gandhi T.K., Kachalia A., Thomas E.J., et al. Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern Med 145 7 (2006) 488-496
39. Welch H.G., and Fisher E.S. Diagnostic testing following screening mammography in the elderly. J Natl Cancer Inst 90 (1998) 1389-1392
40. Bach P.B., Jett J.R., Pastorino U., et al. Computed tomography screening and lung cancer outcomes. JAMA 297 9 (2007) 953-961
41. Jacobs I., and Oram D. Screening for ovarian cancer. Biomed Pharmacother 42 (1988) 589-596
42. Rosenthal A.N., Menon U., and Jacobs I.J. Screening for ovarian cancer. Clin Obstet Gynecol 49 3 (2006) 433-447
43. Welch H.G. Should I be tested for cancer? Maybe not and here's why (2004), University of California Press, California p. 54-5, 77-8
44. Welch H.G., and Black W.C. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?. Ann Intern Med 127 (1997) 1023-1028
45. Bessho F. Effects of mass screening on age-specific incidence of neuroblastoma. Int J Cancer 67 (1996) 520-522
46. Woods W.G., Gao R.N., Shuster J.J., et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med 346 (2002) 1041-1046
47. Schilling F.H., Spix C., Berthold F., et al. Neuroblastoma screening at one year of age. N Engl J Med 346 (2002) 1047-1053
48. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 56 (2006) 11-25
49. U.S. Preventive Services Task Force. Recommendations. Available at: http://www.ahrq.gov/clinic/uspstfix.htm. Accessed April 23, 2007.
50. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 2 (2004) 227-239
51. National Cholesterol Education Program. Estimate of 10-year risk for coronary heart disease: Framingham point scores. Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol/risk_tbl.htm. Accessed April 27, 2007.